Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This chapter reviews low-level light therapy for hair growth and loss prevention but reports no new clinical results, providing an overview of mechanisms, treatments, and future perspectives.

This review discusses techniques for harvesting follicular units, medical treatments for androgenetic alopecia, and potential future advancements in hair restoration therapy, but it reports no new clinical results.

This commentary explores the challenges and considerations in treating female pattern hair loss, with no new clinical findings reported.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

This study suggests that low level laser therapy may promote hair cell regeneration in rat cochlear explants following gentamicin-induced damage.

This review evaluates androgenetic alopecia treatments, highlighting both current options like minoxidil, finasteride, and low-level light therapy, and emerging therapies such as platelet-rich plasma and complex combination treatments, noting their potential and challenges.

This review of non-surgical treatments for androgenetic alopecia reports that combination therapies, particularly platelet-rich plasma with low-level laser therapy, tend to be more effective than using each treatment alone.

Rosemary oil may be a promising and affordable treatment for hair loss.

Higher fluence low-level laser therapy effectively promotes hair growth in androgenetic alopecia, with varying effects based on sex.

This review discusses diffuse unpatterned alopecia (DUPA) as an understudied variant of androgenetic alopecia, summarizing its presentation and management while calling for further research to better understand its distinct characteristics.

This review concluded that non-surgical hair restoration methods, such as pharmacologic and regenerative therapies, are important for delaying or supplementing surgical treatments when used properly.

This review discusses the pathophysiology, molecular events, and therapeutic options for androgenetic alopecia, but reports no new clinical findings.

This source discusses treatment options for androgenetic alopecia in post-operative transgender women, highlighting traditional therapies like minoxidil and finasteride and promising alternatives such as platelet-rich plasma and low-level laser therapy, noting that treatment decisions depend on individual patient circumstances and the availability of specialized research.

This source provides an overview of various treatment options for androgenetic alopecia in post-operative transgender women, highlighting both traditional methods like minoxidil and finasteride, and newer alternatives such as PRP and LLLT, with the choice depending on individual patient circumstances and research availability.

This study determined that low-level light therapy and fractional lasers are effective and safe treatments for androgenetic alopecia, especially when combined with other agents like minoxidil, PRP, or growth factors.

This study found that low-level light therapy and fractional lasers are effective and safe treatments for androgenetic alopecia, with the greatest improvements in hair density and thickness seen in combination therapies.

This study reports that low-level light therapy and fractional lasers are effective and safe treatments for androgenetic alopecia, with more pronounced results when combined with other therapies.

This review highlights that managing androgenetic alopecia in women involves a variety of treatments including approved drugs like minoxidil, as well as newer therapies such as PRP and LLLT, yet emphasizes the need for more research on long-term outcomes and treatment standardization.

This review discusses various management strategies for androgenetic alopecia in women, including approved drugs like minoxidil and emerging therapies such as PRP and LLLT, highlighting the need for research on long-term outcomes and standardization.

This review concluded that laser-based therapies, particularly low-level lasers and fractional ablative lasers, are effective for treating hair loss, with combination therapies showing superior efficacy compared to monotherapies.

This meta-analysis found that laser-based therapies showed promising clinical benefits in treating scarring alopecias, such as disease stabilization and symptom improvement, but highlighted the need for high-quality randomized controlled trials due to serious risk of bias and methodological limitations in existing studies.

This thesis review found that invasive methods like PRP and hair transplantation can significantly improve hair quality and density in androgenetic alopecia, though effectiveness and safety vary by technique.

This review highlights the various causes and treatment options for alopecia, noting that while non-scarring types often see successful hair regrowth, scarring forms require early intervention to manage inflammatory destruction of hair follicles.

This clinical review evaluates current evidence on various adjunctive therapies for androgenetic alopecia, highlighting modest benefits for some interventions but emphasizing significant gaps and the need for rigorous, high-quality research to guide effective management strategies.

This review evaluates PRP, microneedling, and LLLT for alopecia and telogen effluvium, reporting improvements of 30-40% but offers no new clinical data.

This review reports that microneedle-mediated transdermal drug delivery systems show promise in enhancing alopecia treatments by improving the efficacy of various therapeutic agents, including drugs, biologics, and stem cells, but highlights a gap between basic research advancements and clinical trial focus.

This study confirmed that minoxidil is effective for female androgenic alopecia, with suggested additional benefits from therapies like LLLT and PRP, although more research is needed.

This study confirms minoxidil's effectiveness for treating female androgenic alopecia and suggests possible added benefits from therapies like LLLT and PRP, though further research is needed.

This study reviewed treatments and findings related to male androgenetic alopecia, noting that topical minoxidil and oral finasteride are effective for slowing hair loss, while newer interventions like PRP and microneedling show promise.

This review discusses the epidemiology, pathophysiology, diagnosis, and management of male androgenetic alopecia, noting that combination treatments, including FDA-approved and emerging therapies, may improve outcomes without added side effects.